miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway

被引:31
|
作者
Bu, Wenjin [1 ,2 ]
Luo, Tianyou [3 ]
机构
[1] Chongqing Med Univ, Chongqing, Peoples R China
[2] Inner Mongolia Peoples Hosp, Dept Ultrason Med, Hohhot, Peoples R China
[3] Chongqing Med Univ, Dept Radiol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China
关键词
miR-1297; PTEN; Skp2; NSCLC; DOWN-REGULATION; PTEN; APOPTOSIS; GROWTH; SKP2; CHEMORESISTANCE; METASTASIS; EXPRESSION;
D O I
10.1089/dna.2017.3886
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a lipid and protein phosphatase and possesses an antitumor effect in lung cancers. miRNAs are reportedly abnormally expressed in human lung cancers. However, whether miRNA contributes to PTEN expression in non-small cell lung cancers (NSCLCs) has not been clearly clarified. In the present study, we found that miR-1297 probably binds with 3UTR sequence of PTEN and negatively regulated the levels of PTEN in NSCLC cells. First, the expression levels of PTEN and Skp2 were detected by western blotting in NSCLC specimens and paired normal tissue specimens. The results showed that decreased levels of PTEN were detected in NSCLC tissues, compared with paired control tissues (**p<0.01). The expression levels of PTEN were conversely correlated with the levels of Skp2 in clinical NSCLC specimens and NSCLC cell line. Transfection with miR-1297 mimic significantly promoted cell viability of A549 cells and NCI-H460 cells by downregulating the level of PTEN and upregulating the expression of Skp2. Interestingly, knockdown of Skp2 did not affect the expression of PTEN in A549 cells. Thus, miR-1297 might work as an oncogene by regulating PTEN/Akt/Skp2 signaling pathway in NSCLC cells. PTEN and Skp2 might be the potential targets in the clinical therapy of lung cancers.
引用
收藏
页码:976 / 982
页数:7
相关论文
共 50 条
  • [41] ZFPM2-AS1 promotes the proliferation, migration, and invasion of human non-small cell lung cancer cells involving the JAK-STAT and AKT pathways
    Wang, Xiwen
    Tang, Jun
    Zhao, Jungang
    Lou, Bin
    Li, Li
    PEERJ, 2020, 8
  • [42] p27 and SKP2 expression in non-small cell lung cancers (NSCLC)
    Jennings, TA
    Sheehan, CE
    Stringer, B
    Sadis, S
    Brownell, J
    Read, M
    Ross, JS
    MODERN PATHOLOGY, 2003, 16 (01) : 308A - 308A
  • [43] CCDC106 promotes non-small cell lung cancer cell proliferation
    Zhang, Xiupeng
    Zheng, Qin
    Wang, Chen
    Zhou, Haijing
    Jiang, Guiyang
    Miao, Yuan
    Zhang, Yong
    Liu, Yang
    Li, Qingchang
    Qiu, Xueshan
    Wang, Enhua
    ONCOTARGET, 2017, 8 (16) : 26662 - 26670
  • [44] MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN
    Zhu Deng-Yan
    Li Xiang-Nan
    Yu, Qi
    Liu Dong-Lei
    Yang, Yang
    Jia, Zhao
    Zhang Chun-Yang
    Kai, Wu
    Song, Zhao
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 81 : 79 - 85
  • [45] FIGNL1 promotes non-small cell lung cancer cell proliferation
    Li, Miao
    Rui, Yan
    Peng, Wenjia
    Hu, Junfeng
    Jiang, Anbang
    Yang, Zeyu
    Huang, Linian
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (01) : 83 - 99
  • [46] CD44 promotes cell proliferation in non-small cell lung cancer
    Hu, Bo
    Ma, Yuanyuan
    Yang, Yue
    Zhang, Lijian
    Han, Haibo
    Chen, Jinfeng
    ONCOLOGY LETTERS, 2018, 15 (04) : 5627 - 5633
  • [47] LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway (vol 24, pg 222, 2020)
    Wang, Z. -X.
    Xu, Z. -N.
    Sun, H. -B.
    Wang, Y.
    Han, Z. -F.
    Yu, Y.
    Han, X. -L.
    Yin, Y. -Y.
    Xu, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2828 - 2828
  • [48] MiR-378 promotes the cell proliferation of non-small cell lung cancer by inhibiting FOXG1
    Ji, K. -X.
    Cui, F.
    Qu, D.
    Sun, R. -Y.
    Sun, P.
    Chen, F. -Y.
    Wang, S. -L.
    Sun, H. -S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (04) : 1011 - 1019
  • [49] LOVASTATIN SENSITIZES NON-SMALL CELL LUNG CANCER (NSCLC) CELLS TO RADIATION; POSSIBLE INVOLVEMENT OF THE AKT SIGNALING PATHWAY
    Tsakiridis, A.
    Liu, C.
    Tsiani, E.
    Singh, G.
    Wright, J.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S2 - S2
  • [50] KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K/AKT signaling pathway
    Ma, Yue
    Zhang, Yao
    Jiang, Xizi
    Guan, Jingqian
    Wang, Huanxi
    Zhang, Jiameng
    Tong, Yue
    Qiu, Xueshan
    Zhou, Renyi
    SCIENTIFIC REPORTS, 2024, 14 (01):